Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Researcher develops nanoparticle-based tags to detect viruses and cancer with high sensitivity

Researcher develops nanoparticle-based tags to detect viruses and cancer with high sensitivity

Scientists identify new potential target to combat acute myeloid leukemia

Scientists identify new potential target to combat acute myeloid leukemia

Study: Single surface protein can amplify multiple key pathways in acute myeloid leukemia

Study: Single surface protein can amplify multiple key pathways in acute myeloid leukemia

New treatment regimen boosts survival for young adults and children with T-cell malignancies

New treatment regimen boosts survival for young adults and children with T-cell malignancies

Bacterial signals are crucial to development of pre-leukemic myeloproliferation, study shows

Bacterial signals are crucial to development of pre-leukemic myeloproliferation, study shows

Lowering blood cholesterol levels could enhance success of T-cell cancer immunotherapy

Lowering blood cholesterol levels could enhance success of T-cell cancer immunotherapy

Interfering with enzyme's movement may be new approach for developing of anti-cancer drugs

Interfering with enzyme's movement may be new approach for developing of anti-cancer drugs

Researchers test new cancer research model that may reduce cost and speed up studies

Researchers test new cancer research model that may reduce cost and speed up studies

UTA bioengineering professor successfully patents new cancer trap

UTA bioengineering professor successfully patents new cancer trap

Protein researchers identify several new potential targets for cancer

Protein researchers identify several new potential targets for cancer

Why the drugmaker that paid Trump’s lawyer $1.2 million is so worried

Why the drugmaker that paid Trump’s lawyer $1.2 million is so worried

New study aims to mitigate risks associated with treatment of multiple myeloma

New study aims to mitigate risks associated with treatment of multiple myeloma

Aravive Biologics demonstrates proof-of-mechanism for AVB-S6-500 in ongoing phase 1 study

Aravive Biologics demonstrates proof-of-mechanism for AVB-S6-500 in ongoing phase 1 study

New case study shows CAR T therapy as viable option for AML patients

New case study shows CAR T therapy as viable option for AML patients

New findings point to potential therapeutic avenues for leukemia

New findings point to potential therapeutic avenues for leukemia

Moving beyond traditional 'magic bullet' approach for discovering new drugs

Moving beyond traditional 'magic bullet' approach for discovering new drugs

New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy

New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy

Researchers show how Spred1 molecule protects HSC homeostasis under diet-induced stress

Researchers show how Spred1 molecule protects HSC homeostasis under diet-induced stress

Researchers identify protein crucial for leukemia's aggressiveness

Researchers identify protein crucial for leukemia's aggressiveness

Blood biopsies may offer more comprehensive genetic information than bone marrow tests, shows research

Blood biopsies may offer more comprehensive genetic information than bone marrow tests, shows research

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.